Noxopharm Ltd (NOX) - Cash Flow Conversion Efficiency

Latest as of June 2025: -6.614x

Based on the latest financial reports, Noxopharm Ltd (NOX) has a cash flow conversion efficiency ratio of -6.614x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.56 Million ≈ $-3.23 Million USD) by net assets (AU$689.96K ≈ $488.19K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Noxopharm Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Noxopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NOX liabilities breakdown for a breakdown of total debt and financial obligations.

Noxopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Noxopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MRO-TEK Realty Limited NSE:MRO-TEK	0.014x
Careplus Group Bhd KLSE:0163	-0.058x
Excel Realty N Infra Limited NSE:EXCEL	0.000x
Icandy Interactive Ltd AU:ICI	0.017x
NFL Biosciences SAS PA:ALNFL	0.032x
Alligator Bioscience AB ST:ATORX	-3.791x
Hanan Mor TA:HNMR	0.062x
Aerometrex Ltd AU:AMX	0.254x

Annual Cash Flow Conversion Efficiency for Noxopharm Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Noxopharm Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see NOX market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$689.96K ≈ $488.19K	AU$-5.82 Million ≈ $-4.12 Million	-8.442x	-6679.01%
2024-06-30	AU$5.50 Million ≈ $3.89 Million	AU$-684.31K ≈ $-484.19K	-0.125x	+89.68%
2023-06-30	AU$9.07 Million ≈ $6.42 Million	AU$-10.95 Million ≈ $-7.75 Million	-1.206x	-111.87%
2022-06-30	AU$24.12 Million ≈ $17.06 Million	AU$-13.73 Million ≈ $-9.72 Million	-0.569x	-162.35%
2021-06-30	AU$40.78 Million ≈ $28.85 Million	AU$-8.85 Million ≈ $-6.26 Million	-0.217x	+74.91%
2020-06-30	AU$12.87 Million ≈ $9.11 Million	AU$-11.14 Million ≈ $-7.88 Million	-0.865x	-112.84%
2019-06-30	AU$-1.45 Million ≈ $-1.03 Million	AU$-9.78 Million ≈ $-6.92 Million	6.740x	+853.61%
2018-06-30	AU$10.15 Million ≈ $7.18 Million	AU$-9.08 Million ≈ $-6.42 Million	-0.894x	+24.37%
2017-06-30	AU$2.47 Million ≈ $1.75 Million	AU$-2.92 Million ≈ $-2.06 Million	-1.183x	-1179.11%
2016-06-30	AU$5.95 Million ≈ $4.21 Million	AU$-549.72K ≈ $-388.96K	-0.092x	--

About Noxopharm Ltd

AU:NOX Australia Biotechnology

Market Cap

$14.47 Million

AU$20.46 Million AUD

Market Cap Rank

#25923 Global

#1211 in Australia

Share Price

AU$0.07

Change (1 day)

-1.41%

52-Week Range

AU$0.04 - AU$0.13

All Time High

AU$1.58